Latest Articles

Viewpoints

CancerLinQ<sup>TM</sup> Enrolls Practices, Prepares to Usher in 'Big Data Oncology' Era

CancerLinQTM Enrolls Practices, Prepares to Usher in 'Big Data Oncology' Era

ASCO's CancerLinQ go live later this year, ushering in what they described as a transformative era of big data-driven precision cancer care.

Viewpoints ASCO Announces Chronic Leukemia Treatment as Cancer Advance of the Year

ASCO Announces Chronic Leukemia Treatment as Cancer Advance of the Year

The transformation of the treatment of chronic lymphocytic leukemia wins the Society's accolade.

Viewpoints Genetic, Metabolic Factors Are Targets of Research in Renal Cell Carcinoma

Genetic, Metabolic Factors Are Targets of Research in Renal Cell Carcinoma

Recent studies reveal the mechanisms underlying renal cell carcinoma (RCC) and suggest new therapeutic targets.

Multiple Myeloma Multiple myeloma: Optimal management and long-term disease control

Multiple myeloma: Optimal management and long-term disease control

[Blood and Lymphatic Cancer: Targets and Therapy] Myeloma displays considerable heterogeneity and, over time, control of disease can be lost. New strategies to combat myeloma incorporate risk stratification to provide more individualized therapy.

Viewpoints BRCA1/2 and Other Breast Cancer Gene Mutations in Patients Unselected for Family History

BRCA1/2 and Other Breast Cancer Gene Mutations in Patients Unselected for Family History

How frequent are mutations in known breast cancer predisposition genes in women with TNBC who were unselected for family history?

From The Advisory Board Reflecting on Treatment Strategies for Acute Leukemia

Reflecting on Treatment Strategies for Acute Leukemia

Leukemia is sometimes a solid, metastatic, and invasive neoplasm, but this is forgotten when leukemia is viewed as only a "liquid" cancer.

In the Clinic Managing Anticoagulation in Patients with Brain Tumors

Managing Anticoagulation in Patients with Brain Tumors

Patients with brain cancer are at increased risk of deep vein thrombosis and consequently pulmonary embolism.

Lung Cancer The Use of Pharmacogenomics for Selection of Therapy in Non-Small-Cell Lung Cancer

The Use of Pharmacogenomics for Selection of Therapy in Non-Small-Cell Lung Cancer

[Clinical Medicine Insights: Oncology] Performance status is the only known clinical predictor of outcome in patients with advanced non-small-cell lung cancer (NSCLC), but pharmacogenomic markers may also correlate with outcome. This study attempts to correlate clinical and pharmacogenomic measures with overall survival.

Brain Cancer VAL-083 Shows Promise for Glioblastoma Multiforme

VAL-083 Shows Promise for Glioblastoma Multiforme

Phase 2 studies show in vitro effectiveness in various glioblastoma multiforme cell lines, independent of MGMT activity.

General Oncology News Financial Toxicity May Lower Quality of Life in Cancer Patients

Financial Toxicity May Lower Quality of Life in Cancer Patients

Researchers sought to better understand the effect of financial toxitiy on patients with cancer by surveying 1,000 patients.

Viewpoints Early-Onset Prostate Cancer May Be a Unique Clinical Entity

Early-Onset Prostate Cancer May Be a Unique Clinical Entity

Researchers seek better understanding of prostate cancer in young patients.

Viewpoints Entecavir May Be Superior in Lowering HBV-related Hepatitis Incidence in Lymphoma

Entecavir May Be Superior in Lowering HBV-related Hepatitis Incidence in Lymphoma

Recent results on entecavir may change use of lamivudine prophylaxis in cancer patients with the hepatitis B virus.

Viewpoints A New Approach to Assessing Liver Function in Hepatocellular Carcinoma

A New Approach to Assessing Liver Function in Hepatocellular Carcinoma

By analyzing data from international databases, researchers develop an alternative to the Child-Pugh system.

Viewpoints The Unsustainable Costs of Cancer Care: Guidelines to Alleviate the Burden of Cost for Patients

The Unsustainable Costs of Cancer Care: Guidelines to Alleviate the Burden of Cost for Patients

According to a workshop on the high cost of cancer care, oncologists should be empowered and incentivized to use high-value treatment options.

Prostate Cancer Review of CHAARTED Trial Results

Review of CHAARTED Trial Results

CTA Advisory Board member, Neal Shore, MD, puts CHAARTED trial results into context.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs